Acumen Pharmaceuticals, Inc. (ABOS)
3.18
+0.09
(+2.91%)
USD |
NASDAQ |
Sep 04, 16:00
3.17
-0.01
(-0.31%)
After-Hours: 20:00
Acumen Pharmaceuticals Price : 3.18 for Sept. 4, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 04, 2026 | 3.07 | 3.23 | 3.03 | 3.18 | 315433.0 |
| Sep 03, 2026 | 3.13 | 3.165 | 3.05 | 3.09 | 453410.0 |
| Sep 02, 2026 | 2.93 | 3.125 | 2.93 | 3.10 | 247820.0 |
| Sep 01, 2026 | 2.80 | 2.95 | 2.80 | 2.92 | 188968.0 |
| Aug 31, 2026 | 2.90 | 2.92 | 2.76 | 2.85 | 244217.0 |
| Aug 28, 2026 | 3.02 | 3.02 | 2.885 | 2.92 | 305771.0 |
| Aug 27, 2026 | 2.98 | 3.17 | 2.98 | 3.03 | 271066.0 |
| Aug 26, 2026 | 3.09 | 3.09 | 2.915 | 2.99 | 235089.0 |
| Aug 25, 2026 | 3.09 | 3.169 | 3.04 | 3.10 | 300748.0 |
| Aug 24, 2026 | 3.17 | 3.17 | 3.04 | 3.075 | 275963.0 |
| Aug 21, 2026 | 3.21 | 3.34 | 3.135 | 3.16 | 716034.0 |
| Aug 20, 2026 | 3.12 | 3.245 | 3.01 | 3.19 | 599746.0 |
| Aug 19, 2026 | 2.79 | 3.17 | 2.79 | 3.15 | 617832.0 |
| Aug 18, 2026 | 2.66 | 2.79 | 2.636 | 2.74 | 309429.0 |
| Aug 17, 2026 | 2.66 | 2.74 | 2.62 | 2.66 | 412848.0 |
| Aug 14, 2026 | 2.51 | 2.695 | 2.45 | 2.67 | 526703.0 |
| Aug 13, 2026 | 2.50 | 2.55 | 2.39 | 2.55 | 449308.0 |
| Aug 12, 2026 | 2.41 | 2.59 | 2.40 | 2.51 | 487164.0 |
| Aug 11, 2026 | 2.44 | 2.50 | 2.42 | 2.47 | 204689.0 |
| Aug 10, 2026 | 2.41 | 2.45 | 2.37 | 2.43 | 194415.0 |
| Aug 07, 2026 | 2.29 | 2.44 | 2.29 | 2.44 | 256800.0 |
| Aug 06, 2026 | 2.24 | 2.34 | 2.23 | 2.28 | 228246.0 |
| Aug 05, 2026 | 2.26 | 2.295 | 2.22 | 2.24 | 298079.0 |
| Aug 04, 2026 | 2.18 | 2.27 | 2.18 | 2.24 | 283379.0 |
| Aug 03, 2026 | 2.17 | 2.21 | 2.11 | 2.18 | 227454.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biogen, Inc. | 220.83 |
| ACADIA Pharmaceuticals, Inc. | 28.02 |
| Alnylam Pharmaceuticals, Inc. | 266.11 |
| Anika Therapeutics, Inc. | 20.81 |
| Savara, Inc. | 5.37 |
Price Related Metrics
| Price to Book Value | 4.016 |
| Earnings Yield | -51.34% |
| Market Cap | 229.96M |